From this morning's Earlybird:

• "With Democratic Senators continuing to work out a possible 'card check' compromise, organized labor is getting antsy about the exact terms of the deal and worrying that its legislative window may be closing," Roll Call (subscription) reports.

• "Federal Election Commission lawyers have tentatively approved" a request by Rep. Peter Visclosky, D-Ind., "to use his campaign funds to pay legal bills stemming from a Justice Department probe into the Indiana Democrat's ties with the now defunct PMA Group," Politico reports.

• As Obama "prepares to take his much maligned health care plan into the lion's den -- the American Medical Association -- at least one doctor is waiting with potentially fatal questions," The Hill reports. "Dr. Donald Palmisano, a former AMA president, said Sunday that most of the scuttlebutt surrounding the conference that the president will address Monday in Chicago is full of vagueness and skepticism."

• Lobbyists who want Congress to approve a swift pathway to generic versions of biotech drugs say the Federal Trade Commission last week handed their side a boost just as Congress wades into the health care reform debate," Roll Call (subscription) reports. "But biotech brand companies, which have billions of dollars at stake, stepped up their own lobbying efforts, calling the FTC report flawed and working to give their side momentum on Capitol Hill."